Astute Medical (United States)

Recent papers from Astute Medical (United States)

1. Validation of Urinary C-C Motif Chemokine Ligand 14 for Persistent Severe AKI Using Clinical AdjudicationClinical Journal of the American Society of Nephrology · 2026
2. Abstract 4297: COX-2/PGE2 driven, photoimmunotherapy-induced edema is reduced by prophylactic NSAIDs in mouse tumor modelsCancer Research · 2026
3. Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney InjuryCritical Care Explorations · 2023
4. Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 PatientsJournal of health economics and outcomes research · 2023
5. Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 PatientsJournal of health economics and outcomes research · 2023
6. Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 PatientsJournal of health economics and outcomes research · 2023
7. Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI PatientsKidney360 · 2022
8. Performance of a Standardized Clinical Assay for Urinary C–C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney InjuryKidney360 · 2022
9. Clinical Outcomes of Persistent Severe Acute Kidney Injury among Patients with Kidney Disease Improving Global Outcomes Stage 2 or 3 Acute Kidney InjuryAmerican Journal of Nephrology · 2022
10. External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injuryCritical Care · 2021
11. Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation*Critical Care Medicine · 2021
12. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY studyIntensive Care Medicine · 2020
13. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical IllnessCardiorenal Medicine · 2019
14. Analytical characteristics of a biomarker-based risk assessment test for acute kidney injury (AKI)Clinica Chimica Acta · 2016